首页 | 本学科首页   官方微博 | 高级检索  
     检索      


Caspase 3 inhibitor Ac-DEVD-CHO attenuates 10-hydroxycamptothecin-induced activation of NF-κB in Bcap37 cells
Authors:YE Meng  LIN Lei  PAN Hong-ming  FANG Yong  WU Jin-min
Institution:1.Department of Oncology,2Department of Dermatology,The Affiliated Hospital,Ningbo University,Ningbo 315020,China;3.Department of Oncology,Sir Run Run Shaw Hospital,Zhejiang University,Hangzhou 310016,China. E-mail: dryemeng@yahoo.com.cn
Abstract:AIM:To investigate the role of caspase 3 inhibitor Ac-DEVD-CHO in caspase 3 signaling pathway and NF-κB activation induced by 10-hydroxycamptothecin (HCPT) in human breast carcinoma cells. METHODS:The cell growth inhibition was measured by MTT assay. Agarose gel electrophoresis was performed for detecting cell apoptosis. Western blotting was used for determining protein expression. DIG-EMSA was conducted to measure the DNA-binding activation of NF-κB. RESULTS:Caspase 3 inhibitor Ac-DEVD-CHO attenuated HCPT-induced apoptosis in human breast carcinoma. Ac-DEVD-CHO also suppressed the degradation of caspase 3 and IκBα,and arrested the activation of NF-κB. CONCLUSION:Caspase 3 inhibitor Ac-DEVD-CHO regulates the activation of caspase 3 and NF-κB,and attenuates apoptosis in Bcap37 cell line induced by HCPT.
Keywords:Camptothecin  Caspase 3 inhibitor  Apoptosis  NF-kappa B  
点击此处可从《园艺学报》浏览原始摘要信息
点击此处可从《园艺学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号